Literature DB >> 17309780

Cytokine profile of t lymphocytes from peripheral blood and bronchoalveolar lavage fluid in patients with active pulmonary tuberculosis.

Z Boras1, A Juretić, A Gagro, Lj Pavelić.   

Abstract

The possible immunological relationship between the pattern of Th1/Th2 cytokine production and tuberculin reactivity was assessed in patients with active Mycobacterium tuberculosis infection. The production of the intracellular cytokines interferon (IFN)-gamma and interleukin-4 (IL-4) was measured in CD4(+) and CD8(+) T cells obtained from peripheral blood and bronchoalveolar lavage fluid (BALF) of 20 tuberculin skin-positive patients and compared with the findings recorded in nine tuberculin skin-negative patients with active pulmonary tuberculosis. Upon stimulation with phorbol 12-myristate acetate/ionomycin for 6 h, tuberculin-negative patients had a significantly higher proportion of IFN-gamma-producing CD4(+) T lymphocytes in BALF than in peripheral blood, while both CD4(+) and CD8(+) T-lymphocyte subsets in BALF of tuberculin-positive patients secreted more IFN-gamma than their peripheral blood counterparts. Tuberculin-negative patients had a significantly higher proportion of IFN-gamma-producing CD4(+) T lymphocytes in peripheral blood than tuberculin-positive patients. There was no significant difference in the production of IFN-gamma by BALF CD4(+) T lymphocytes, or by either peripheral blood or BALF CD8(+) T lymphocytes. In two tuberculin-negative patients, peripheral blood CD4(+) T lymphocytes produced IL-4. Study results suggested a higher immune activity in the blood of tuberculin-negative patients, with an increased lymphocyte activity in BALF versus peripheral blood in both patient groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309780     DOI: 10.1111/j.1365-3083.2006.01890.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Role of flexible bronchoscopy in patients with sputum-negative pulmonary tuberculosis.

Authors:  Satyaprakash Sanjeevaiah; Maruti Yamanappa Haranal; Shashidhar Buggi
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-02-12

Review 2.  Harnessing local and systemic immunity for vaccines against tuberculosis.

Authors:  P C L Beverley; S Sridhar; A Lalvani; E Z Tchilian
Journal:  Mucosal Immunol       Date:  2013-11-20       Impact factor: 7.313

3.  Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area.

Authors:  Niclas Winqvist; Per Björkman; Ann Norén; Håkan Miörner
Journal:  BMC Infect Dis       Date:  2009-07-03       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.